LINKTIGA
Live / Allowed — Fourth extension granted (statement of use) (as of 20 Jan 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Mar 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 97859271
- Mark type
- Word mark
- Filed
- 27 Mar 2023
- Published for opposition
- 23 Jan 2024
- Attorney of record
- Kristen S. Ruisi
Goods and services
- Class 005 — Pharmaceuticals: Medicines, pharmaceutical preparations, chemico-pharmaceutical preparations, biological preparations for medical purposes, chemical preparations for medical purposes, all of the foregoing for the treatment of cancer and rheumatoid arthritis; diagnostic biomarker reagents for medical purposes; pharmaceuticals for the treatment of cancer, autoimmune and inflammatory diseases and infectious diseases
Owner
- BEONE MEDICINES I GMBH, BASEL, CH
- BeiGene Switzerland GmbH, Basel, CH
- BeiGene Switzerland GmbH, Basel, CH
Prosecution history
- 21 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Jan 2026 — SOU EXTENSION 4 GRANTED
- 20 Jan 2026 — SOU EXTENSION 4 FILED
- 20 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 12 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Aug 2025 — SOU EXTENSION 3 GRANTED
- 11 Aug 2025 — SOU EXTENSION 3 FILED
- 11 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Jul 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 09 Jul 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 04 Jun 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 10 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Feb 2025 — SOU EXTENSION 2 GRANTED
- 07 Feb 2025 — SOU EXTENSION 2 FILED
- 07 Feb 2025 — SOU TEAS EXTENSION RECEIVED